Press release
Non-alcoholic Steatohepatitis Market Study with Current and Upcoming Trends, Leading Players – ALLERGAN, Gilead Sciences, Novartis AG, Pfizer, Algernon Pharmaceuticals, Celerion
Non-alcoholic Steatohepatitis Market
Get FREE Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-non-alcoholic-steatohepatitis-market&rp
Market Analysis: Global Non-alcoholic Steatohepatitis Market
Global non-alcoholic steatohepatitis market is set to witness healthy CAGR of 56.15% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing demand for NASH therapeutics and increasing presence of pipeline drugs are the factor for the growth.
Key Market Competitors:
Few of the major competitors currently working in the global non-alcoholic steatohepatitis market are ALLERGAN, Zydus Cadila, Conatus Pharmaceuticals Inc, Galmed Pharmaceuticals Ltd, Gemphire, Genfit SA, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., Novartis AG, Shire, Enzo Biochem Inc., Novo Nordisk A/S, Immuron, Pfizer Inc., Algernon Pharmaceuticals, Celerion, NuSirt Biopharma, Perspectum Diagnostics., Boehringer Ingelheim International GmbH and others.
Get Full TOC, Tables and Figures of Market Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-non-alcoholic-steatohepatitis-market&rp
Market Definition: Global Non-alcoholic Steatohepatitis Market
Nonalcoholic steatohepatitis (NASH) is a kind of a non-alcoholic fatty liver disease (NAFLD) which usually occurs when fat is collected in the liver. It usually causes inflammation and also damages the liver cell. NASH usually occurs on people who don’t consume alcohol. Itis very common in patients with conditions such as hypertension, type 2 diabetes, high blood lipid, heart disease, and others. NASH can also cause problems like liver cancer and cirrhosis. According to researchers, about 3 to 12 percentage of population in United States is suffering from nonalcoholic steatohepatitis.
Segmentation: Global Non-alcoholic Steatohepatitis Market
Non-alcoholic Steatohepatitis Market : By Drug Type
Vitamin E & Pioglitazone
Ocaliva
Obeticholic acid
Elafibranor
Selonsertib & Cenicriviroc
Others
Non-alcoholic Steatohepatitis Market : By Sales Channel
Hospital Pharmacy
Online Provider
Retail Pharmacy
Non-alcoholic Steatohepatitis Market : By Disease Cause
Hypertension
Heart Disease
High Blood Lipid
Type 2 Diabetes
Obesity
Non-alcoholic Steatohepatitis Market : End User
Hospitals
Clinics
Homecare settings
Non-alcoholic Steatohepatitis Market : By Geography
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Non-alcoholic Steatohepatitis Market : Drivers
Increasing cases of diabetes and obesity is driving the growth of the market
Growing Nonalcoholic steatohepatitis (NASH) affected population worldwide will also drive the market growth
Rising healthcare expenditure will also propel the market growth
Increasing launches of pipeline drugs will also contribute as a factor for the growth of this market
Non-alcoholic Steatohepatitis Market : Restraints
Lack of proper diagnostic technologies for Nonalcoholic steatohepatitis (NASH) will restrain the market growth
Less demand in the underdeveloped countries is another factor restraining the market growth
Key Developments in the Market:
In July 2019, Altimmune, Inc announced that they have acquired Spitfire Pharma, Inc along with their product candidate SP-1373 to treat non-alcoholic steatohepatitis (NASH). The main aim of the acquisition is to help the company to meet the requirement of the people for treatment of Nonalcoholic steatohepatitis (NASH). This acquisition will strengthen the company’s position in the market and will provide better treatment to their patients
In July 2019, InSphero AG launched their new 3D InSight Human Liver Disease Discovery Platform which is specially designed for the safety testing of nonalcoholic steatohepatitis drugs and nonalcoholic fatty liver disease. The main aim of this launch is to meet the increasing demand of research community for efficient and fast screening of the drug candidates
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-non-alcoholic-steatohepatitis-market&rp
Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com
About Data Bridge Market Research:
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-alcoholic Steatohepatitis Market Study with Current and Upcoming Trends, Leading Players – ALLERGAN, Gilead Sciences, Novartis AG, Pfizer, Algernon Pharmaceuticals, Celerion here
News-ID: 2138143 • Views: …
More Releases from Data Bridge Market Research Pvt. Ltd.
The Digital Landscape: Examining the Surge in Media Monitoring Software Market V …
For an excellent business growth, companies must take up market research report service which is imperative in today's market place. "Media Monitoring Software Market" research report has been produced with a nice blend of industry insight, smart and practical solutions and newest technology to endow with the better user experience. The report brings into focus several aspects related to industry and market. A few of these can be listed here…
Animal Antibiotics Antimicrobials Market Sales to Top USD 6.3 billion by 2029
Antimicrobials are substances that kill or inhibit the majority of germs. The antimicrobials can be natural, semi-synthetic, or synthetic. Antibiotics are all antimicrobials, but antimicrobials aren't all antibiotics. Antibiotics are basically used to treat clinical illness, prevent and manage common disease occurrences, and improve animal development and growth. They are used in food animals in three ways: therapeutic, prophylactic, and sub-therapeutic. Antimicrobials offer significant advantages in terms of animal…
Benzene Market Research 2021-2028: China National Petroleum Corporation, Haldia …
Market research reports help business or organization in every sphere of trade to take better decisions, to respond the toughest business questions and reduce the risk of failure. In the world class Benzene market report, data collection modules with large sample sizes are used to collect data and perform base year analysis. The market research data included in this report is analysed and forecasted using market statistical and coherent models.…
Digital Inks Market Report 2021-2027: Cabot Corporation, INX International Ink C …
Digital Inks Market research reports are very influential in many ways to grow the business. Digital Inks market report is a superior and comprehensive market research report which endows professionals with a lot of aspects about the market and the industry. The marketing report presents market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, their preferences for particular product and market demand and…
More Releases for Steatohepatitis
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non-Alcoholic Steatohepatitis Treatment Market Size, Share
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Non-Alcoholic Steatohepatitis Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $2.67 billion In 2028…
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
Nonalcoholic Steatohepatitis Treatment Market Analysis
As per the research conducted by GME, the Global Nonalcoholic Steatohepatitis Treatment Market will grow with a CAGR value of 39.1% by 2026. Over the forecast era, the production of NASH biomarkers is expected to be aided by increasing demand for non-invasive diagnostic tools and increased patient awareness. The low use of invasive procedures for disease diagnosis is due to the high cost of liver biopsy, its invasiveness, and patients'…
Emerging Opportunities in Nonalcoholic Steatohepatitis Therapeutics Market
Global Nonalcoholic Steatohepatitis (NASH) Market: Snapshot
Nonalcoholic Steatohepatitis (NASH), a syndrome found in non-alcoholic patients, causes damage to liver that is histologically akin to alcoholic hepatitis. NASH results from fat in the liver, along with inflammation. Symptoms in NASH usually do not show, but it can be severe and lead to cirrhosis, which is permanent damage to the liver.
Those suffering from obesity, dyslipidemia, and glucose intolerance are most likely…
